About Bioline  All Journals  Testimonials  Membership  News  Donations

European Journal of General Medicine
Medical Investigations Society
ISSN: 1304-3897
Vol. 6, No. 3, 2009, pp. 187-188
Bioline Code: gm09040
Full paper language: English
Document type: Research Article
Document available free of charge

European Journal of General Medicine, Vol. 6, No. 3, 2009, pp. 187-188

 en Primary breast lymphoma treated with R-CHOP chemotherapy
Karagöz, Bülent; Bilgi, Oğuz; Erikçi, Alev Akyol; Özgun, Alpaslan; Türken, Orhan & Kandemir, Emin Gökhan


Primary breast lymphoma is rare disease which is treated with surgery, radiotherapy and chemoterapy. There is little experience of rituximab treatment is in breast lymphoma. Here we pres-ent a case of primary breast lymhoma treated with rituximab and chemotherapy combination. A 58-year-old woman referred for left breast mass. Radiologic imaging showed a mass of 4 cm in diameter. Pathologic examination of excisional biopsy specimen revealed Diffuse Large B Cell Lymphoma with CD20 positivity. The patient was stage IE (Ann Arbor). Mastectomy, lumpectomy or axil-lary dissection were not performed. Six courses of R-CHOP (CHOP plus rituximab) chemotherapy and radiotherapy were given. The complete response was obtained. The patient has been followed for 36 months with no evidence of disease recurrence. This is one of the first cases treated with rituximab. She has been followed for more than 36 months without relapse.

Breast lymphoma, rituximab, extranodal non-Hodgkin lymphoma

© Copyright 2009 European Journal of General Medicine.
Alternative site location:

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2020, Site last up-dated on 29-Jan-2020.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Internet Data Center of Rede Nacional de Ensino e Pesquisa, RNP, Brazil